Exploring biomarkers and early diagnosis in Alzheimer's disease: a bibliometric analysis from 2013 to 2023

Abstract

This study conducts a thorough bibliometric analysis spanning 2013 to 2023 to explore advancements in Alzheimer's disease (AD) biomarker research. Examining scholarly literature encompassing pivotal biomarkers—beta-amyloid proteins, tau, neurofilament light chain, and advanced imaging techniques—emphasizes their significance in early diagnosis and disease progression monitoring. Unveiling emerging trends and collaborative networks, this analysis deciphers the multidimensional landscape of AD biomarker research, providing critical insights. Findings serve as a foundational guide for future research endeavors and targeted interventions in the complex realm of AD.